Aurinia Pharmaceuticals, Inc. (AUPH)
14.74
-0.30
(-1.99%)
USD |
NASDAQ |
Mar 05, 16:00
14.70
-0.04
(-0.27%)
After-Hours: 07:33
Aurinia Pharmaceuticals Cash from Investing (TTM) : -32.84M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Xenon Pharmaceuticals, Inc. | 218.46M |
| Oncolytics Biotech, Inc. | -0.0052M |
| Edesa Biotech, Inc. | 0.00 |
| Lexaria Bioscience Corp. | -0.2103M |
| ProMIS Neurosciences, Inc. | -0.0007M |